BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by moneywagonon Nov 23, 2022 4:07pm

140 Views

Post# 35123210

BIOV CIBC WALKED IT DOWN ON 500 ICEBERG SELL LOTS ALGOS SET

FUKERS manipulating the share price UNTIL that newswire gets spit out!! WE SHOULD OPEN HIGHER TOMORROW!! Those @20's are so close I can taste them!!~ hmmmm
Need to move up to that next increment we deserve it!!

Recent Trades - Last 10 of 24

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:22:13	C	0.16	-0.015	200	124 Questrade	79 CIBC	E
15:22:13	C	0.16	-0.015	3,500	79 CIBC	79 CIBC	K
15:00:22	U	0.16	-0.015	6,000	1 Anonymous	2 RBC	K
14:32:36	C	0.16	-0.015	10,000	79 CIBC	79 CIBC	K
13:52:06	U	0.17	-0.005	50	79 CIBC	7 TD Sec	E
13:23:04	O	0.165	-0.01	500	2 RBC	79 CIBC	K
13:23:04	O	0.165	-0.01	500	2 RBC	79 CIBC	K
13:23:04	O	0.165	-0.01	500	2 RBC	79 CIBC	K
13:23:04	O	0.165	-0.01	500	2 RBC	79 CIBC	K
13:23:04	O	0.165	-0.01	500	2 RBC	79 CIBC	K